Clinical trial
Quality of Life Analysis of Prostate Cancer Patient's Therapy
NCT00692874 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quality of Life Analysis of Prostate Cancer Patient's Therapy
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- September 30, 2010
- Enrollment
- 1,646 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer